Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) has announced the appointment of Eran Kuratz as head of supply chain and business process administration for its wholly owned subsidiary, Scinai Biopharma Services Ltd. The move is part of the company’s strategy to strengthen its contract development and manufacturing organization (CDMO) platform, which recently expanded through the acquisition of Recipharm Israel.
Kuratz brings more than 30 years of leadership, supply chain, and operational experience across the pharmaceutical, biotechnology, medical-device, and industrial sectors. In his new role, he will oversee procurement, contracting, inventory management, logistics, budgeting, IT and business systems, cybersecurity, and cross-functional business processes. His appointment is effective immediately.
This development follows Scinai’s first-quarter 2026 acquisition of Recipharm Israel, which added a second development and manufacturing site in Yavne. Combined with Scinai’s existing operations in Jerusalem, the expanded platform now provides capabilities spanning biologics process development, aseptic manufacturing, sterile fill-and-finish, small-molecule active pharmaceutical ingredient (API) development and synthesis, analytical-method development, and GMP manufacturing.
The strategic expansion positions Scinai to offer a wider range of services to biotechnology and pharmaceutical companies. By integrating Kuratz’s expertise, the company aims to enhance operational efficiency and ensure robust supply chain management, which are critical to meeting the demands of its growing client base.
Scinai Immunotherapeutics is a biopharmaceutical company focused on developing innovative immunology therapies. Its pipeline includes therapeutic candidates licensed from the Max Planck Society and from PinCell S.r.l. In addition to its CDMO services, the company continues to advance its own drug development programs.
The appointment of Kuratz is a clear signal that Scinai is prioritizing operational excellence as it scales its CDMO business. With the addition of the Yavne facility and now a seasoned supply chain executive, Scinai is well-positioned to compete in the highly competitive CDMO market.
For more information on Scinai’s latest developments, visit the company’s newsroom at https://ibn.fm/SCNI. The full press release is available at https://ibn.fm/d9ktl.
